ads

Search This Blog

Saturday, 30 November 2013

Syndicate Bank Multibagger 2 yrs timeframe Trgt 150 Rs

Syndicate Bank Multibagger 2 yrs timeframe Trgt 150 Rs





  • Syndicate bank was started in Karnataka Udipi district with a seed capital of 8000 Rs by 3 people.
Open cheapest Brokerage account in India

  • There piggy bank scheme under which they where collecting 2 Anna's in old days are now collecting 2 crores daily. it's a door step service where they go and collect in each house.
  • They have implemented CBS in all There branches and hence complain with RBI guidelines.
  • Bank also has aggresive expansion plan on coming years.
  • With a strong EPS growth of more than 50% in past 1 year, we see this company reach new height. 
  • We are giving a target of Rs 150 in 2 yrs time frame
Open cheapest Brokerage account in India

Jaiprakash Associates Multibagger 3 yrs time frame Long term - Trgt 128

Jaiprakash Associates Multibagger 3 yrs time frame Long term - Trgt 128

 
 
 
  • A company founded by Gaur in late 1960's is a conglomerate which focus on infrastructure space.
  • The sectors they focus are Cement,Engineering,Sports,education ,power and realestate
  • The company Main brand is the JP cements which is one of the flagship product of the company
  • They are also pioner in ydor power project with many succesful hydro projects in operation.
  • There Golf course and FI budda track show the company ability to meet international standards
  • Their Main problem has been the mountain of Debts that they have accumulated.
  • But now the managmeent has realized it and started selling some of its assets to reduce the debt
  • As part of the restructuring they are selling thier Cement plant to Ultra tech.
  • They have total debt of 550 billion of which the company is planning to reduce to 400 billion this year 2014.
  • So if they go at this pace they will be debt free company in another 3 yrs time frame.
  • With debt reducing we see EPS improving and hence we see this stock close to 120 Rs minimum.
  • One can invest in this stock for 3 yrs time frame.
 

Wednesday, 20 November 2013

Jaypee Infratech - Multibagger 2yrs timeframe Trgt - Rs 40





  • A infrastructure development and real estate commpany with a vison to particiate and grow the Infrastrucre space.
  • JIL is an infrastructure development company engaged in the development of the flagship project Yamuna Expressway and other real estate projects in the country.
  • The company came in to existance in April 2007 Special Purpose to develop, operate and maintain the Yamuna Expressway in Uttar Pradesh, connecting Noida and Agra. 
  • This highway is a 165-kilometre Tolled six-lane highway along the river Yamuna, with the potential to be widened to an eight-lane highway
  • The company also has the right to develop 25 million square metres (approximately 6,175 acres) of land along the Yamuna Expressway at five locations for residential, commercial, amusement, industrial and institutional purposes which will act as a Butter for the effort and time the company has put in for this project.
  • We see the company to reach in 40 Rs level in 2yrs timeframe once it starts selling the properties along the highway.


Tuesday, 12 November 2013

Idea Cellular -Multibagger Trgt 2 yrs timeframe



  • Idea Cellular an Aditya Birla Group Company, has a pan-India integrated GSM operator offering 2G and 3G services, and has its own NLD and ILD operations.
  • With revenue of $4 billion; revenue market share of nearly 15%; and subscriber base of over 121 million in FY 2013, Idea is India’s 3rd largest mobile operator.
  • Idea’s robust pan-India coverage is built on a network of over 100,000 2G and 3G cell sites, spread across over 55,000 towns in India.
  • Company has nearly 4,500 exclusive Idea outlets, and over 7,000 call centre seats giving top class service to their customer.
  • With sales of over Rs 22000 crores and and profit of 5000 crores this company is to become the next Airtel of India.
  • One can buy with target of  320 Rs  of 2 yrs timeframe 

Sunday, 10 November 2013

Aurobindo Pharma Multibagger Trgt 350 Rs 1 yr time frame


  • Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy 2 aspiring business man who had taken it for a small group to big 7500 cr company.This shows their commitment towards the company.
  • Aurobindo Pharma features among the top 10 companies in India in terms of consolidated revenues. Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations. 
  • Theirnportfolio consist of Semi-Synthetic Penicillins, neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins.
  •  The companies formulation business is systematically organized with a divisional structure, and has a focused team for key international markets. Leveraging on its large manufacturing infrastructure for APIs and formulations, wide and diversified basket of products and  confidence of its customers, it aims to achieve USD 2 billion revenues by 2015-16.
  • With strong growth ,diversed portfolio,strong leadership and R&D we see this company reach 350 Rs in 1 yr timeframe.

Thursday, 7 November 2013

GlaxoSmithKline Pharmaceuticals - Multibagger 2 Yrs timeframe 3200 Rs

GlaxoSmithKline Pharmaceuticals - Multibagger 2 Yrs timeframe 3500 Rs









  • The company started operations in 1924 in India is one of the oldest pharmaceuticals in the country. Glaxo product are trusted by Doctors and have got thier blessings.
  • Thery are very famous amang Infant Foods.The have manufacturing units in Aligar,Worli,Bangalore,Nasik.
  • In 1983 the company reduced it states from 75 % to 40%.
  •  Globally, Glaxo is a £ 26.4 billion, leading, research-based healthcare and pharmaceutical company.
  • In India they do a turnover of 3200 Crore Ruppes whihc contitnue to 4% of ther companys tottal turnover.
  • Their India product portfolio includes prescription medicines and vaccine ssuch as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases.
  • The company is the market leader in most of the therapeutic categories in which it operates.They also offer range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.
  • With a huge cash flow and strong growth with Company might increase its stake to 75% in lines of HUL, we recommend to buy this Stock with a Target of 3500 rS IN 2YRS time frame.

Tuesday, 5 November 2013

Reliance Communication - Multi bagger Trgt 245 1 year time frame

Reliance Communication - Multi bagger Trgt 245 1 year time frame



  • This Anil Ambani group flagship company, is getting back in Race.
  •  Reliance Communications, is India's largest private sector information and communications company, with over 150 million subscribers. 
  • Reliance Group has  established a pan-India, high-capacity, integrated (wireless and wireline), convergent (voice, data and video) digital network.
  • Recently their consolidated profit has increased to 3.2 %.
  • With Mukesh Ambani stepping in this company will grow in its leaps and bound.
  • Also the way Chinese banks have shown interest, this will be a company for acquisition if it fails.
  • With all these good things coming, We expect the stock to go to 240+ in 1 yr time frame.

Sunday, 3 November 2013

Rakesh Jhunjhunwala Diwali Picks -2013


  • India's ace bull investor,Rakesh Jhunjhunwala is bullish on Auto sector.
  • He see's that the auto sector has consolidated for long and it will start up move .
  • He is especially bullish on 2 stocks in Auto sector,they are TATA MOTORS and EICHER MOTORS.
  • Currently TM is trading at 386 Rs we see 20 to30 % .So one an invest in the stocks with 1 year timeframe.
  • EICHER Motors which is trading at 3892 Rs. We again see 20 to 30 %.

Friday, 1 November 2013

Glenmark Pharmaceuticals - Multibagger Trgt 750 Rs in 2 yrs


  • Glenmark  a leading company in discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development.
  • Glenmark  revenue is of USD 32 Million, the company is currently ranked among the World's top 100 Pharma & Biotech companies.
  • SCRIP  a leading magazine had  recognized Glenmark as 'Best Pharma Company in the World – SME' and 'Best Company in an Emerging Market' in 2008.
  • Company has 14 manufacturing facilities in four countries and has 6 R&D centres.
  • With strong growth we expect the company to deliver 40 % growth.
  • One can buy with Trgt with 750 Rs.